Systems Biology Approach for Cancer Vaccine Development and Evaluation
Therapeutic cancer vaccines do not hold promise yet as an effective anti-cancer treatment. Lack of efficacy or poor clinical outcomes are due to several antigenic and immunological aspects that need to be addressed in order to reverse such trends and significantly improve cancer vaccines’ efficacy....
Main Authors: | Luisa Circelli, Annacarmen Petrizzo, Maria Tagliamonte, Maria Lina Tornesello, Franco M. Buonaguro, Luigi Buonaguro |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-07-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | http://www.mdpi.com/2076-393X/3/3/544 |
Similar Items
-
High Somatic Mutation and Neoantigen Burden Do Not Correlate with Decreased Progression-Free Survival in HCC Patients not Undergoing Immunotherapy
by: Angela Mauriello, et al.
Published: (2019-11-01) -
Use of adjuvants for immunotherapy
by: Luisa Circelli, et al.
Published: (2017-08-01) -
Nanoparticles to Improve the Efficacy of Peptide-Based Cancer Vaccines
by: Anna Lucia Tornesello, et al.
Published: (2020-04-01) -
Unique true predicted neoantigens (TPNAs) correlates with anti-tumor immune control in HCC patients
by: Annacarmen Petrizzo, et al.
Published: (2018-10-01) -
Virus-like Particles as Preventive and Therapeutic Cancer Vaccines
by: Anna Lucia Tornesello, et al.
Published: (2022-02-01)